Author:
Zhang Yong,Wu Xianxian,Li Yang,Zhang Haiying,Li Zhange,Zhang Ying,Zhang Longyin,Ju Jiaming,Liu Xin,Chen Xiaohui,Glybochko Peter V.,Nikolenko Vladimir,Kopylov Philipp,Xu Chaoqian,Yang Baofeng
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Zhang, T., Zhang, P., Wang, S. & Han, T. Preliminary clinical observations of 6 cases of leukemia treated by “Ailin solution”. Med Pharm Heilongjiang. 3, 66–67 (1973).
2. Cyranoski, D. Arsenic patent keeps drug for rare cancer out of reach of many. Nat Med. 13, 1005 (2007).
3. Gazitt, Y. & Akay, C. Arsenic trioxide: an anti cancer missile with multiple warheads. Hematology. 10, 205–213 (2005).
4. Zhai, B. et al. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation. Tumour Biol. 36, 2323–2334 (2015).
5. Singer, J. W. Cardiac toxicity of arsenic trioxide. Blood. 98, 1633; author reply 1633–1634 (2001).
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献